Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies Press release
Galderma’s Restylane® Volyme™ demonstrates high effectiveness, satisfaction and a robust safety profile in Chinese patients with temple hollowing Press release
Galderma receives European Union approval for Restylane® Shaype™: the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping Press release
Galderma launches Alastin® in Japan and key markets across Asia Pacific, expanding its footprint in the region Press release
Landmark global Galderma survey shows 9 out of 10 people are affected by skin quality concerns Press release
Galderma unveils new global survey data exploring the evolving expectations and experiences of patients and healthcare professionals with anti-wrinkle treatments Press release
Galderma receives U.S. FDA approval for Differin® Epiduo® Acne Gel Prescription-to-OTC switch Press release
Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform Press release
Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause Press release
